BioSpace News Archive

Career Advice

How to Answer Popular Behavioral Questions in the Job Interview

A growing number of employers are asking “behavioral questions” in the job interview. If you’re currently on the job market, you should spend some time researching the most likely behavioral questions you’ll be asked in your next interview, how you can prepare for these questions, and the best answers.

May 8, 2018

·

3 min read

Shire Under Pressure to Break Up the Business

Deals

It’s Official! Takeda Pharma to Buy Shire for $62.2 Billion

Dublin-based Shire agreed to be acquired by Japan-based Takeda Pharmaceutical, with both boards approving the deal.

May 8, 2018

·

3 min read

·

Mark Terry

Business

Valeant to Change its Name to Bausch Health Companies, Reports Loss in First Quarter

Valeant Pharmaceuticals will change its name to Bausch Health Companies Inc. in July of this year. The company will rebrand itself with the highly recognizable name of its subsidiary eye-care company Bausch + Lomb.

May 8, 2018

·

3 min read

·

Alex Keown

Career Advice

10 Must-Watch Ted Talks if You’re on the Job Market

Check out these 10 inspiring, motivating Ted Talks when you’re on the job market. They’ll make you think, look your goals and fears squarely in the face, and give you some much-needed perspective during a time of great change and opportunity.

May 8, 2018

·

2 min read

Virtual brain innovative technology in science and medical concept in blue tone

Drug Development

Alnylam’s Preclinical Data Supports CNS Delivery of RNA Interference Therapies

Alnylam Pharmceuticals reported preclinical results that supports advancement of its RNA interference (RNAi) therapeutics for central nervous system disorders into the clinic.

May 8, 2018

·

3 min read

·

Mark Terry

Drug Development

Auris Medical Snags CHMP Approval to Launch Another Phase III Trial for AM-111

Shares of Switzerland-based Auris Medical Holding AG shot up nearly 10 percent Monday after the company announced it received clearance to begin a new Phase III trial for AM-111, the company’s investigational treatment for acute inner ear hearing loss.

May 8, 2018

·

2 min read

·

Alex Keown

Deals

Two Chinese Pharma Companies, WuXi AppTec and Ascletis Pharma, List IPOs on Asian Exchanges

Shares of Chinese pharmaceutical and medical device company WuXi AppTec were a hot commodity Tuesday as the company made its debut on the Shanghai Stock Exchange. Another Chinese company, Ascletis Pharma, also chose a new stock listing.

May 8, 2018

·

3 min read

·

Alex Keown

Pictured: Pile of money/iStock, Ihor Lukianenko

Deals

Aurobindo Pharma Bids $1.6 Billion for Novartis’ Generics Dermatology Business

Novartis’ generics division, Sandoz, has been struggling in the face of intense pricing pressure. As a result, Novartis has been looking to sell off some of its Sandoz businesses.

May 8, 2018

·

3 min read

·

Mark Terry

Biotech Bay

NeuCyte Inc. Closes $6.7 Million Series A Financing

SUNNYVALE, Calif., May 8, 2018 /PRNewswire/ -- NeuCyte, Inc., a leading neuroscience drug discovery company, announced the closing of a Series A financing round of $6.7 million, for a totaled funding of more than $8 million. NeuCyte’s initial investors, Cowin Venture and Leaguer Ventures, led the round.

May 8, 2018

·

4 min read

Business

GenomeDx Biosciences Announces Research Collaboration with Janssen Pharmaceuticals to Evaluate the Decipher® Classifier and Decipher GRID® for Drug Development

GenomeDx Biosciences announced a research collaboration with Janssen Pharmaceuticals.

May 8, 2018

·

2 min read